Anna Wallerstedt Lantz

8PUBLICATIONS
27CO-AUTHORS
MortalityMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 12, 2026
The performance of prostate-specific antigen density in long-term prostate cancer-mortality risk prediction.

|May 08, 2024
Prostate cancer incidence and mortality in men exposed to α1-adrenergic receptor antagonists.

Lars Björnebo, Shirin Razdan, Andrea Discacciati

|Oct 19, 2023
Revisiting Delphi to Create a Basis for the Future of Focal Therapy for Prostate Cancer.

Lara Rodríguez-Sánchez, Mark Emberton, Theo de Reijke

|Mar 04, 2021
A 4K score/MRI-based nomogram for predicting prostate cancer, clinically significant prostate cancer, and unfavorable prostate cancer.

Vinayak G Wagaskar, Stanislaw Sobotka, Parita Ratnani

|Sep 01, 2020
Incorporating Magnetic Resonance Imaging and Biomarkers in Active Surveillance Protocols - Results From the Prospective Stockholm3 Active Surveillance Trial (STHLM3AS).

Henrik Olsson, Tobias Nordström, Fredrik Jäderling

|May 31, 2020
Effect of information on prostate biopsy history on biopsy outcomes in the era of MRI-targeted biopsies.

Anna Lantz, Erik Skaaheim Haug, Wolfgang Picker

Pageof 2

Frequent Collaborators

2 joint publications

Gunnar Steineck

2 joint publications

Martin Eklund

1 joint publications

Anders Bjartell

1 joint publications

Henrik Olsson